Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
 Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT01351103
15:21:cancer
patients with tumors of any histological origin with documented genetic alterations upstream in the Wnt signaling pathway (e.g. RNF43 or RSPO fusion) are eligible with prior agreement with Novartis
2
[ "patients", "with", "tumors", "of", "any", "histological", "origin", "with", "documented", "genetic", "alterations", "upstream", "in", "the", "Wnt", "signaling", "pathway", "(", "e.g", ".", "RNF43", "or", "RSPO", "fusion", ")", "are", "eligible", "with", "prio...
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01525901
1:13:chronic_disease
valvulopathy
2
[ "valvulopathy" ]
[ 2 ]
NCT02477839
13:21:chronic_disease,49:65:chronic_disease,93:118:chronic_disease,120:141:cancer,145:163:chronic_disease
Subject has epilepsy secondary to a progressing cerebral disease or any other progressively neurodegenerative disease (malignant brain tumor or Rasmussen Syndrome)
2
[ "Subject", "has", "epilepsy", "secondary", "to", "a", "progressing", "cerebral", "disease", "or", "any", "other", "progressively", "neurodegenerative", "disease", "(", "malignant", "brain", "tumor", "or", "Rasmussen", "Syndrome", ")" ]
[ 0, 0, 2, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 2, 2, 0, 3, 3, 3, 0, 2, 2, 0 ]
NCT02473354
18:37:chronic_disease
has a history of sickle cell disease [self-reported]
2
[ "has", "a", "history", "of", "sickle", "cell", "disease", "[", "self-reported", "]" ]
[ 0, 0, 0, 0, 2, 2, 2, 0, 0, 0 ]
NCT02243813
7:28:chronic_disease
Has a psychiatric condition judged to be incompatible with establishment of rapport or safe exposure to psilocybin
2
[ "Has", "a", "psychiatric", "condition", "judged", "to", "be", "incompatible", "with", "establishment", "of", "rapport", "or", "safe", "exposure", "to", "psilocybin" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03018704
1:34:chronic_disease
imminent suicide or violence risk
2
[ "imminent", "suicide", "or", "violence", "risk" ]
[ 2, 2, 2, 2, 2 ]
NCT02509546
14:42:cancer
Diagnosis of acute promyelocytic leukemia
2
[ "Diagnosis", "of", "acute", "promyelocytic", "leukemia" ]
[ 0, 0, 3, 3, 3 ]
NCT02546583
,37:45:treatment
At least 6 hours since last dose of diuretic
2
[ "At", "least", "6", "hours", "since", "last", "dose", "of", "diuretic" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02043548
,21:32:treatment,34:38:treatment,42:58:treatment
3 month washout for leflunomide, IVIg or cyclophosphamide
2
[ "3", "month", "washout", "for", "leflunomide", ",", "IVIg", "or", "cyclophosphamide" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 1 ]
NCT02541903
1:25:cancer
ductal carcinoma in situ
2
[ "ductal", "carcinoma", "in", "situ" ]
[ 3, 3, 3, 3 ]
NCT02068092
14:46:cancer,48:63:treatment,68:87:cancer
Diagnosis of lobular carcinoma in situ (LCIS), atypical ductal, or lobular hyperplasia
2
[ "Diagnosis", "of", "lobular", "carcinoma", "in", "situ", "(", "LCIS", ")", ",", "atypical", "ductal", ",", "or", "lobular", "hyperplasia" ]
[ 0, 0, 3, 3, 3, 3, 3, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02458482
98:128:treatment,
Patients who present from a referring facility or Primary Care Physician (PCP) and have received systemic corticosteroids (SCS) within one hour of initial AAIRS scoring will also be included
2
[ "Patients", "who", "present", "from", "a", "referring", "facility", "or", "Primary", "Care", "Physician", "(", "PCP", ")", "and", "have", "received", "systemic", "corticosteroids", "(", "SCS", ")", "within", "one", "hour", "of", "initial", "AAIRS", "scoring", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01430390
15:19:treatment,100:113:treatment,165:177:treatment,
The patient's HSCT donor, or if HSCT donor is not available a third party donor, must consent to a leukapheresis or whole blood donation(s) obtained at one or more phlebotomies which, in aggregate, will total approximately 250 ml for adults and no more than 5ml/kg per draw from pediatric donors
2
[ "The", "patient", "'s", "HSCT", "donor", ",", "or", "if", "HSCT", "donor", "is", "not", "available", "a", "third", "party", "donor", ",", "must", "consent", "to", "a", "leukapheresis", "or", "whole", "blood", "donation", "(", "s", ")", "obtained", "at", ...
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02455193
13:40:chronic_disease,48:73:chronic_disease,82:102:chronic_disease
Significant endocrine/metabolic disease (e.g., uncontrolled hypertension, severe hypertriglyceridemia)
2
[ "Significant", "endocrine/metabolic", "disease", "(", "e.g.", ",", "uncontrolled", "hypertension", ",", "severe", "hypertriglyceridemia", ")" ]
[ 0, 2, 2, 0, 0, 0, 2, 2, 0, 0, 2, 0 ]
NCT02145351
9:33:chronic_disease
Chronic stable exertional angina
2
[ "Chronic", "stable", "exertional", "angina" ]
[ 0, 2, 2, 2 ]
NCT02507011
1:20:treatment,
RVEF by cardiac MRI < 45%
2
[ "RVEF", "by", "cardiac", "MRI", "<", "45", "%" ]
[ 1, 1, 1, 1, 0, 0, 0 ]
NCT02479698
1:50:cancer
Merkel polyoma-virus related Merkel cell tumor(s) with measurable disease on imaging per RECIST criteria
2
[ "Merkel", "polyoma-virus", "related", "Merkel", "cell", "tumor", "(", "s", ")", "with", "measurable", "disease", "on", "imaging", "per", "RECIST", "criteria" ]
[ 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02202369
36:56:treatment
Subjects undergoing a single level lumbar decompression and fusion
2
[ "Subjects", "undergoing", "a", "single", "level", "lumbar", "decompression", "and", "fusion" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0 ]
NCT02845596
1:48:chronic_disease
Inherited bone marrow failure syndromes (IBMFS)
2
[ "Inherited", "bone", "marrow", "failure", "syndromes", "(", "IBMFS", ")" ]
[ 2, 2, 2, 2, 2, 2, 0, 0 ]
NCT02700451
,,22:42:treatment
Require 1 or 2 level lumbar spinal fusion through posterior or lateral approach
2
[ "Require", "1", "or", "2", "level", "lumbar", "spinal", "fusion", "through", "posterior", "or", "lateral", "approach" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02504866
3:30:treatment
A ventriculo-peritoneal shunt
2
[ "A", "ventriculo-peritoneal", "shunt" ]
[ 0, 1, 1 ]
NCT02351544
67:89:treatment,107:124:chronic_disease,115:124:chronic_disease
Those patients are included because there is no consensus whether surgical decompression is effective for chronic migraines only, or for chronic and episodic migraines. One of the goals of this trial is to determine this
2
[ "Those", "patients", "are", "included", "because", "there", "is", "no", "consensus", "whether", "surgical", "decompression", "is", "effective", "for", "chronic", "migraines", "only", ",", "or", "for", "chronic", "and", "episodic", "migraines", ".", "One", "of", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01734512
1:22:cancer
Pilocytic Astrocytoma - 90600112
2
[ "Pilocytic", "Astrocytoma", "-", "90600112" ]
[ 3, 3, 0, 0 ]
NCT00338377
18:33:treatment,61:73:treatment,74:87:treatment
Is not receiving B-RAF treatment (Cohort C) (Turnstile II - Chemotherapy/Cell Infusion Exclusion Criteria)
2
[ "Is", "not", "receiving", "B-RAF", "treatment", "(", "Cohort", "C", ")", "(", "Turnstile", "II", "-", "Chemotherapy/Cell", "Infusion", "Exclusion", "Criteria", ")" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT01420887
36:52:treatment
Not possible to have postoperative physical therapy appointment
2
[ "Not", "possible", "to", "have", "postoperative", "physical", "therapy", "appointment" ]
[ 0, 0, 0, 0, 0, 1, 1, 0 ]
NCT02262832
17:28:treatment
Availability of metreleptin to the patient either as an approved drug, or through local compassionate use or expanded access programs
2
[ "Availability", "of", "metreleptin", "to", "the", "patient", "either", "as", "an", "approved", "drug", ",", "or", "through", "local", "compassionate", "use", "or", "expanded", "access", "programs" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02522715
1:16:treatment
Metastatic CRPC
2
[ "Metastatic", "CRPC" ]
[ 1, 1 ]
NCT02538198
71:83:treatment
no dosing or adverse event data are currently available on the use of lenalidomide in patients
2
[ "no", "dosing", "or", "adverse", "event", "data", "are", "currently", "available", "on", "the", "use", "of", "lenalidomide", "in", "patients" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT02122081
29:103:treatment,
Interval between completing treatment with a hypomethylating agent or other non-cytotoxic chemotherapy and the start of conditioning regimen must be at least 10 days
2
[ "Interval", "between", "completing", "treatment", "with", "a", "hypomethylating", "agent", "or", "other", "non-cytotoxic", "chemotherapy", "and", "the", "start", "of", "conditioning", "regimen", "must", "be", "at", "least", "10", "days" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01787682
26:46:treatment
Current use of long-term oral corticosteroids (CHF only)
2
[ "Current", "use", "of", "long-term", "oral", "corticosteroids", "(", "CHF", "only", ")" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02490631
9:18:chronic_disease
Current infection
2
[ "Current", "infection" ]
[ 0, 2 ]
NCT01990209
,,,51:64:chronic_disease
New York Heart Association (NYHA) Class III or IV heart failure
2
[ "New", "York", "Heart", "Association", "(", "NYHA", ")", "Class", "III", "or", "IV", "heart", "failure" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02167009
12:33:treatment,35:49:treatment,54:71:treatment
History of open prostate surgery, radiofrequency, or microwave therapy
2
[ "History", "of", "open", "prostate", "surgery", ",", "radiofrequency", ",", "or", "microwave", "therapy" ]
[ 0, 0, 1, 1, 1, 0, 1, 0, 0, 1, 1 ]
NCT01619761
,,,,283:295:treatment
Woman with child bearing potential must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME, at least 4 weeks before she starts taking lenalidomide
2
[ "Woman", "with", "child", "bearing", "potential", "must", "either", "commit", "to", "continued", "abstinence", "from", "heterosexual", "intercourse", "or", "begin", "TWO", "acceptable", "methods", "of", "birth", "control", ",", "one", "highly", "effective", "metho...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01794559
17:28:treatment,,63:76:treatment,94:97:treatment,
ble to stop all medications (wash out) for 5 half-lves of all medication(s) which affect the EEG. Outpatient subjects are eligible if they can be washed out of their medications in 14 days or less
2
[ "ble", "to", "stop", "all", "medications", "(", "wash", "out", ")", "for", "5", "half-lves", "of", "all", "medication", "(", "s", ")", "which", "affect", "the", "EEG", ".", "Outpatient", "subjects", "are", "eligible", "if", "they", "can", "be", "washed",...
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT03143153
11:28:cancer
Must have esophageal cancer that cannot be operated on, or treated with definitive chemoradiation with curative intent, that is advanced, reoccurring or has spread out
2
[ "Must", "have", "esophageal", "cancer", "that", "can", "not", "be", "operated", "on", ",", "or", "treated", "with", "definitive", "chemoradiation", "with", "curative", "intent", ",", "that", "is", "advanced", ",", "reoccurring", "or", "has", "spread", "out" ]
[ 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01444209
28:33:cancer,54:57:treatment,61:63:treatment
Patients must have visible tumor on imaging studies (MRI or CT)
2
[ "Patients", "must", "have", "visible", "tumor", "on", "imaging", "studies", "(", "MRI", "or", "CT", ")" ]
[ 0, 0, 0, 0, 3, 0, 0, 0, 0, 1, 0, 1, 0 ]
NCT03086369
9:33:cancer
Current hematologic malignancies
2
[ "Current", "hematologic", "malignancies" ]
[ 0, 3, 3 ]
NCT02429934
15:31:chronic_disease,42:46:treatment,50:64:treatment,,99:115:treatment
Subjects with active infection requiring oral or IV antibiotics within one month of first dose of study medication
2
[ "Subjects", "with", "active", "infection", "requiring", "oral", "or", "IV", "antibiotics", "within", "one", "month", "of", "first", "dose", "of", "study", "medication" ]
[ 0, 0, 2, 2, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01420887
18:34:chronic_disease
Current or prior septic arthritis
2
[ "Current", "or", "prior", "septic", "arthritis" ]
[ 0, 0, 0, 2, 2 ]
NCT02033941
35:41:chronic_disease
History of clinically significant stroke
2
[ "History", "of", "clinically", "significant", "stroke" ]
[ 0, 0, 0, 0, 2 ]
NCT01591356
38:60:chronic_disease,90:102:chronic_disease,126:147:chronic_disease,151:166:chronic_disease,,,252:284:chronic_disease,294:312:chronic_disease,347:382:chronic_disease,409:446:chronic_disease,465:477:chronic_disease
Patients with clinically significant cardiovascular disease; this includes: uncontrolled hypertension (greater than 140/90); myocardial infarction or unstable angina within 6 months prior to registration; New York Heart Association (NYHA) grade II or greater congestive heart failure; serious cardiac arrhythmia requirin...
2
[ "Patients", "with", "clinically", "significant", "cardiovascular", "disease", ";", "this", "includes", ":", "uncontrolled", "hypertension", "(", "greater", "than", "140/90", ")", ";", "myocardial", "infarction", "or", "unstable", "angina", "within", "6", "months", ...
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 2, 0, 2, 2, 2, 2, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
NCT01591356
19:22:treatment,60:62:treatment,,,,,354:365:treatment
when imaging (DCE-MRI, DW-MRI and PET-computed tomography [CT] imaging) is being performed for secondary objectives (dose level III [or when the dose reaches at least 1,500 ug/m^2] and during the expansion phase) at least one lesion (>= 2 cm) not adjacent to the diaphragm will be required when measured by conventional ...
2
[ "when", "imaging", "(", "DCE-MRI", ",", "DW-MRI", "and", "PET-computed", "tomography", "[", "CT", "]", "imaging", ")", "is", "being", "performed", "for", "secondary", "objectives", "(", "dose", "level", "III", "[", "or", "when", "the", "dose", "reaches", "...
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
NCT03077243
1:15:chronic_disease
Systemic lupus
2
[ "Systemic", "lupus" ]
[ 2, 2 ]
NCT01365169
110:116:cancer
During clinician's pre-surgical evaluation, presents with high risk for non-therapeutic resection related to cancer diagnosis (PCS study)
2
[ "During", "clinician", "'s", "pre-surgical", "evaluation", ",", "presents", "with", "high", "risk", "for", "non-therapeutic", "resection", "related", "to", "cancer", "diagnosis", "(", "PCS", "study", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT00383656
,32:61:chronic_disease,85:97:cancer,101:116:cancer,130:137:treatment,167:179:treatment,196:220:treatment,224:242:treatment,247:255:cancer,259:281:cancer
Women and minors with acquired hypogonadotropic hypogonadism will have a history of hypothalamic or pituitary tumor treated with surgery alone or in combination with radiotherapy or a history of hypothalamic irradiation as adjunctive therapy for leukemia or craniofacial neoplasms
2
[ "Women", "and", "minors", "with", "acquired", "hypogonadotropic", "hypogonadism", "will", "have", "a", "history", "of", "hypothalamic", "or", "pituitary", "tumor", "treated", "with", "surgery", "alone", "or", "in", "combination", "with", "radiotherapy", "or", "a",...
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 1, 1, 3, 3, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 3, 0, 3, 3 ]
NCT02474199
1:11:treatment,
Prednisone: maximum dose of 5mg daily
2
[ "Prednisone", ":", "maximum", "dose", "of", "5mg", "daily" ]
[ 1, 0, 0, 0, 0, 0, 0 ]
NCT01696734
1:12:chronic_disease
heart block
2
[ "heart", "block" ]
[ 2, 2 ]
NCT02862938
17:45:chronic_disease,,71:91:chronic_disease,113:133:chronic_disease
Participant has choroidal neovascularization secondary to age related macular degeneration or any other type of retinal degeneration that may interfere with the study procedures, evaluations and outcome assessments
2
[ "Participant", "has", "choroidal", "neovascularization", "secondary", "to", "age", "related", "macular", "degeneration", "or", "any", "other", "type", "of", "retinal", "degeneration", "that", "may", "interfere", "with", "the", "study", "procedures", ",", "evaluation...
[ 0, 0, 2, 2, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03123783
29:40:chronic_disease,55:70:treatment
History of (non-infectious) pneumonitis that required corticosteroids or current pneumonitis
2
[ "History", "of", "(", "non-infectious", ")", "pneumonitis", "that", "required", "corticosteroids", "or", "current", "pneumonitis" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 1, 0, 0, 0 ]
NCT02570854
14:34:chronic_disease,,,,,
Uncontrolled renal osteodystrophy defined asthe coexistence of all of the following at screening (1) intact PTH ≥ 750 pg/mL, (2) serum phosphate above the upper limit of the lab normal range, and (3) calcium x phosphate product > 75 mg2/dL2 (6.05 mmol2/L2)
2
[ "Uncontrolled", "renal", "osteodystrophy", "defined", "asthe", "coexistence", "of", "all", "of", "the", "following", "at", "screening", "(", "1", ")", "intact", "PTH", "≥", "750", "pg/mL", ",", "(", "2", ")", "serum", "phosphate", "above", "the", "upper", ...
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02932280
15:52:cancer
Patients with primary central nervous system tumors
2
[ "Patients", "with", "primary", "central", "nervous", "system", "tumors" ]
[ 0, 0, 3, 3, 3, 3, 3 ]
NCT02159703
1:37:chronic_disease
symptomatic congestive heart failure
2
[ "symptomatic", "congestive", "heart", "failure" ]
[ 2, 2, 2, 2 ]
NCT02273362
21:43:treatment,
Receiving any other investigational agents =< 6 months prior to registration
2
[ "Receiving", "any", "other", "investigational", "agents", "=", "<", "6", "months", "prior", "to", "registration" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02159495
104:113:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biological composition to cetuximab
2
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biological", "composition", "to", "cetuximab" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4 ]
NCT03090607
21:84:chronic_disease
History of or known esophageal stricture or gross esophageal anatomic abnormalities
2
[ "History", "of", "or", "known", "esophageal", "stricture", "or", "gross", "esophageal", "anatomic", "abnormalities" ]
[ 0, 0, 0, 0, 2, 2, 2, 2, 2, 2, 2 ]
NCT02468453
31:40:treatment,42:54:treatment,58:102:treatment,,122:131:treatment
Subject has systemically used retinoids, antioxidants or medical grade of skin nourishing supplements within 2 months of treatment or during the study
2
[ "Subject", "has", "systemically", "used", "retinoids", ",", "antioxidants", "or", "medical", "grade", "of", "skin", "nourishing", "supplements", "within", "2", "months", "of", "treatment", "or", "during", "the", "study" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT02389465
76:86:allergy_name,90:102:allergy_name,114:123:allergy_name,125:132:allergy_name,143:149:allergy_name,218:230:allergy_name
Known history of relevant severe drug allergy or hypersensitivity (e.g. to Citalopram or Escitalopram, and/or to celecoxib, aspirin, or other NSAIDs only for Phase 2; known demonstration of allergic-type reactions to sulfonamides)
2
[ "Known", "history", "of", "relevant", "severe", "drug", "allergy", "or", "hypersensitivity", "(", "e.g", ".", "to", "Citalopram", "or", "Escitalopram", ",", "and/or", "to", "celecoxib", ",", "aspirin", ",", "or", "other", "NSAIDs", "only", "for", "Phase", "2...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 4, 0, 0, 0, 4, 0, 4, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0 ]
NCT02573376
9:22:chronic_disease
Chronic HCV infection as documented by quantifiable HCV RNA
2
[ "Chronic", "HCV", "infection", "as", "documented", "by", "quantifiable", "HCV", "RNA" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT03006302
1:21:chronic_disease
intercurrent illness
2
[ "intercurrent", "illness" ]
[ 2, 2 ]
NCT02438995
22:31:treatment
Previous exposure to Cetuximab
2
[ "Previous", "exposure", "to", "Cetuximab" ]
[ 0, 0, 0, 1 ]
NCT03133793
8:42:treatment
Recent percutaneous coronary intervention
2
[ "Recent", "percutaneous", "coronary", "intervention" ]
[ 0, 1, 1, 1 ]
NCT02740595
1:18:chronic_disease
Diabetes mellitus
2
[ "Diabetes", "mellitus" ]
[ 2, 2 ]
NCT02725177
21:31:cancer,55:85:cancer,89:116:cancer,121:147:cancer,
Have any history of malignancy, except fully resected cutaneous squamous cell cancer or cutaneous basal cell cancer, or cervical carcinoma in-situ with a minimum of 5 years period without recurrence
2
[ "Have", "any", "history", "of", "malignancy", ",", "except", "fully", "resected", "cutaneous", "squamous", "cell", "cancer", "or", "cutaneous", "basal", "cell", "cancer", ",", "or", "cervical", "carcinoma", "in-situ", "with", "a", "minimum", "of", "5", "years"...
[ 0, 0, 0, 0, 3, 0, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02637947
26:32:chronic_disease,
subject has a history of stroke within 1 month prior to enrollment
2
[ "subject", "has", "a", "history", "of", "stroke", "within", "1", "month", "prior", "to", "enrollment" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0 ]
NCT03069716
12:34:chronic_disease
Functional class IV heart failure
2
[ "Functional", "class", "IV", "heart", "failure" ]
[ 0, 2, 2, 2, 2 ]
NCT02563678
16:33:treatment,
presenting for hyperbaric oxygen for acute carbon monoxide poisoning (up to 3 sessions)
2
[ "presenting", "for", "hyperbaric", "oxygen", "for", "acute", "carbon", "monoxide", "poisoning", "(", "up", "to", "3", "sessions", ")" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01505569
1:27:cancer
extraneural metastases, M4
2
[ "extraneural", "metastases", ",", "M4" ]
[ 3, 3, 3, 0 ]
NCT02473250
10:23:chronic_disease
lifetime schizophrenia
2
[ "lifetime", "schizophrenia" ]
[ 0, 2 ]
NCT02502006
1:12:chronic_disease,14:22:chronic_disease,26:41:chronic_disease
coagulation, bleeding or blood disorders
2
[ "coagulation", ",", "bleeding", "or", "blood", "disorders" ]
[ 2, 0, 2, 0, 2, 2 ]
NCT03130218
8:31:chronic_disease,40:46:chronic_disease,50:94:chronic_disease
Severe reactive airway disease such as asthma or chronic obstructive pulmonary disease (COPD)
2
[ "Severe", "reactive", "airway", "disease", "such", "as", "asthma", "or", "chronic", "obstructive", "pulmonary", "disease", "(", "COPD", ")" ]
[ 0, 2, 2, 2, 0, 0, 2, 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02634957
1:28:chronic_disease
Sub-epithelial fibrous mass
2
[ "Sub-epithelial", "fibrous", "mass" ]
[ 2, 2, 2 ]
NCT02522715
1:18:treatment,,,,
Aminoglutethimide; approximate half-life: 15 hours; washout period required: 4 days
2
[ "Aminoglutethimide", ";", "approximate", "half-life", ":", "15", "hours", ";", "washout", "period", "required", ":", "4", "days" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02213289
17:37:chronic_disease
No uncontrolled intercurrent illness or infection
2
[ "No", "uncontrolled", "intercurrent", "illness", "or", "infection" ]
[ 0, 0, 2, 2, 0, 0 ]
NCT01835626
1:24:treatment,7:16:treatment,123:142:treatment
Prior radiation therapy is acceptable but there cannot be major overlap of the previously irradiated tissues with the new radiation treatment volumes anticipated to be delivered for the purposes of this protocol, in such a way that curative intent with radiation cannot be met
2
[ "Prior", "radiation", "therapy", "is", "acceptable", "but", "there", "can", "not", "be", "major", "overlap", "of", "the", "previously", "irradiated", "tissues", "with", "the", "new", "radiation", "treatment", "volumes", "anticipated", "to", "be", "delivered", "f...
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02237183
1:25:cancer
non-melanoma skin cancer
2
[ "non-melanoma", "skin", "cancer" ]
[ 3, 3, 3 ]
NCT02047474
16:21:cancer,264:288:treatment,285:287:treatment,295:314:treatment,319:351:treatment,391:394:treatment
No evidence of tumor extension to superior mesenteric artery, hepatic artery, celiac axis, aorta, or inferior vena cava, and no evidence of occlusion or encasement of the superior mesenteric vein or superior mesenteric vein/portal vein confluence, as assessed by computed tomography (CT) using pancreatic protocol (or ma...
2
[ "No", "evidence", "of", "tumor", "extension", "to", "superior", "mesenteric", "artery", ",", "hepatic", "artery", ",", "celiac", "axis", ",", "aorta", ",", "or", "inferior", "vena", "cava", ",", "and", "no", "evidence", "of", "occlusion", "or", "encasement",...
[ 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 1, 1, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0...
NCT02076906
10:29:treatment,31:43:treatment,45:63:treatment,65:82:treatment,104:118:treatment,109:118:treatment
No other anti-cancer therapy (chemotherapy, biological therapy, radiation therapy) is permitted during HIFU treatment and post treatment follow up for tolerability
2
[ "No", "other", "anti-cancer", "therapy", "(", "chemotherapy", ",", "biological", "therapy", ",", "radiation", "therapy", ")", "is", "permitted", "during", "HIFU", "treatment", "and", "post", "treatment", "follow", "up", "for", "tolerability" ]
[ 0, 0, 1, 1, 0, 1, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02901067
1:17:chronic_disease,,
Thrombocytopenia (platelet count < 50,000)
2
[ "Thrombocytopenia", "(", "platelet", "count", "<", "50,000", ")" ]
[ 2, 0, 0, 0, 0, 0, 0 ]
NCT03182907
41:44:chronic_disease
At screening has suspected or confirmed CDI
2
[ "At", "screening", "has", "suspected", "or", "confirmed", "CDI" ]
[ 0, 0, 0, 0, 0, 0, 2 ]
NCT02101853
28:44:chronic_disease
Patients with uncontrolled seizure disorder
2
[ "Patients", "with", "uncontrolled", "seizure", "disorder" ]
[ 0, 0, 0, 2, 2 ]
NCT02772302
1:26:chronic_disease
Minimally conscious state
2
[ "Minimally", "conscious", "state" ]
[ 2, 2, 2 ]
NCT02176902
24:28:allergy_name
Patient has allergy to fish
2
[ "Patient", "has", "allergy", "to", "fish" ]
[ 0, 0, 0, 0, 4 ]
NCT01880567
17:20:chronic_disease,28:37:treatment,43:52:treatment
Newly diagnosed MCL: Prior treatment with ibrutinib
2
[ "Newly", "diagnosed", "MCL", ":", "Prior", "treatment", "with", "ibrutinib" ]
[ 0, 0, 2, 0, 0, 1, 0, 1 ]
NCT01624090
,47:76:treatment
At least 3 half-lives must have elapsed since monoclonal antibody treatment
2
[ "At", "least", "3", "half-lives", "must", "have", "elapsed", "since", "monoclonal", "antibody", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT00391170
24:41:chronic_disease
Clinically significant oral chronic GVHD at the time of the screening
2
[ "Clinically", "significant", "oral", "chronic", "GVHD", "at", "the", "time", "of", "the", "screening" ]
[ 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02431806
24:48:chronic_disease
Clinically significant cardiovascular disorders
2
[ "Clinically", "significant", "cardiovascular", "disorders" ]
[ 0, 0, 2, 2 ]
NCT02061553
8:25:chronic_disease
active suicidal ideation
2
[ "active", "suicidal", "ideation" ]
[ 0, 2, 2 ]
NCT02312518
18:38:chronic_disease
Subjects who are cognitively impaired and do not have a healthcare proxy
2
[ "Subjects", "who", "are", "cognitively", "impaired", "and", "do", "not", "have", "a", "healthcare", "proxy" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02316886
51:76:treatment,
Contraindication to or planned discontinuation of dual antiplatelet therapy within 1 year
2
[ "Contraindication", "to", "or", "planned", "discontinuation", "of", "dual", "antiplatelet", "therapy", "within", "1", "year" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0 ]
NCT02512926
,103:125:chronic_disease,132:141:cancer,143:155:chronic_disease
Patients must meet the WHO classification with ≥ 5% blasts in the bone marrow or must have definitive extramedullary disease (e.g. chloromas, skin lesions)
2
[ "Patients", "must", "meet", "the", "WHO", "classification", "with", "≥", "5", "%", "blasts", "in", "the", "bone", "marrow", "or", "must", "have", "definitive", "extramedullary", "disease", "(", "e.g", ".", "chloromas", ",", "skin", "lesions", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 3, 0, 2, 2, 0 ]
NCT02995733
22:33:allergy_name
Known allergy to the ICS inhaler used in the study
2
[ "Known", "allergy", "to", "the", "ICS", "inhaler", "used", "in", "the", "study" ]
[ 0, 0, 0, 0, 4, 4, 0, 0, 0, 0 ]
NCT02159027
78:98:chronic_disease
Ability and willingness to provide written informed consent Mild to moderate cognitive impairment with global neuropsychological (NP) test (NPZglobal)
2
[ "Ability", "and", "willingness", "to", "provide", "written", "informed", "consent", "Mild", "to", "moderate", "cognitive", "impairment", "with", "global", "neuropsychological", "(", "NP", ")", "test", "(", "NPZglobal", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02132598
26:48:treatment,60:98:treatment,103:118:treatment,126:135:treatment,139:149:treatment,161:192:treatment,,213:225:treatment,227:238:treatment,,285:294:treatment
The subject has received cytotoxic chemotherapy (including investigational cytotoxic chemotherapy) or biologic agents (e.g., cytokines or antibodies; including investigational biologic agents) within 3 weeks, or nitrosoureas/ mitomycin C within 6 weeks before the first dose of study treatment
2
[ "The", "subject", "has", "received", "cytotoxic", "chemotherapy", "(", "including", "investigational", "cytotoxic", "chemotherapy", ")", "or", "biologic", "agents", "(", "e.g.", ",", "cytokines", "or", "antibodies", ";", "including", "investigational", "biologic", "...
[ 0, 0, 0, 0, 1, 1, 0, 0, 1, 1, 1, 0, 0, 1, 1, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02471430
1:6:chronic_disease
HIV-1 infection prior to entry
2
[ "HIV-1", "infection", "prior", "to", "entry" ]
[ 2, 0, 0, 0, 0 ]
NCT02979366
,61:76:treatment
already enrolled in the study who has received at least one S64315 infusion
2
[ "already", "enrolled", "in", "the", "study", "who", "has", "received", "at", "least", "one", "S64315", "infusion" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02953509
1:18:cancer,
Second malignancy within the last 3 years
2
[ "Second", "malignancy", "within", "the", "last", "3", "years" ]
[ 3, 3, 0, 0, 0, 0, 0 ]
NCT02523443
21:35:treatment,36:57:treatment,64:77:treatment
Patients taking any opioid agonist/antagonist medication (i.e. Buprenorphine)
2
[ "Patients", "taking", "any", "opioid", "agonist/antagonist", "medication", "(", "i.e", ".", "Buprenorphine", ")" ]
[ 0, 0, 0, 1, 1, 1, 0, 0, 0, 1, 0 ]
NCT02494141
12:27:treatment,
History of hospitalization within the last 3 months
2
[ "History", "of", "hospitalization", "within", "the", "last", "3", "months" ]
[ 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02053909
12:39:chronic_disease
History of gastrointestinal hemorrhage
2
[ "History", "of", "gastrointestinal", "hemorrhage" ]
[ 0, 0, 2, 2 ]